SEHK:241

Stock Analysis Report

Alibaba Health Information Technology

Executive Summary

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republic of China.


Snowflake Analysis

High growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Alibaba Health Information Technology's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 241's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.2%

241

6.4%

HK Healthcare Services

5.3%

HK Market


1 Year Return

43.0%

241

42.0%

HK Healthcare Services

-20.4%

HK Market

Return vs Industry: 241 exceeded the Hong Kong Healthcare Services industry which returned 42% over the past year.

Return vs Market: 241 exceeded the Hong Kong Market which returned -20.4% over the past year.


Shareholder returns

241IndustryMarket
7 Day2.2%6.4%5.3%
30 Day-12.4%-5.6%-8.5%
90 Day40.9%12.8%-14.7%
1 Year43.0%43.0%42.2%42.0%-17.6%-20.4%
3 Year264.3%264.3%123.1%121.4%-2.5%-12.3%
5 Year89.7%89.7%51.9%50.7%-5.7%-20.9%

Price Volatility Vs. Market

How volatile is Alibaba Health Information Technology's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Alibaba Health Information Technology undervalued compared to its fair value and its price relative to the market?

132016.39x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 241 (HK$12.86) is trading above our estimate of fair value (HK$6.66)

Significantly Below Fair Value: 241 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 241 is poor value based on its PE Ratio (132016.4x) compared to the Healthcare Services industry average (40.5x).

PE vs Market: 241 is poor value based on its PE Ratio (132016.4x) compared to the Hong Kong market (9.1x).


Price to Earnings Growth Ratio

PEG Ratio: 241 is poor value based on its PEG Ratio (1021.7x)


Price to Book Ratio

PB vs Industry: 241 is overvalued based on its PB Ratio (27.7x) compared to the XA Healthcare Services industry average (4.6x).


Next Steps

Future Growth

How is Alibaba Health Information Technology forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

129.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 241's forecast earnings growth (129.2% per year) is above the savings rate (1.6%).

Earnings vs Market: 241's earnings (129.2% per year) are forecast to grow faster than the Hong Kong market (11.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 241's revenue (56.5% per year) is forecast to grow faster than the Hong Kong market (10.2% per year).

High Growth Revenue: 241's revenue (56.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 241's Return on Equity is forecast to be low in 3 years time (19.7%).


Next Steps

Past Performance

How has Alibaba Health Information Technology performed over the past 5 years?

7.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 241 has a large one-off gain of CN¥64.2M impacting its September 30 2019 financial results.

Growing Profit Margin: 241 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 241 has become profitable over the past 5 years, growing earnings by 7.7% per year.

Accelerating Growth: 241 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 241 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare Services industry (32%).


Return on Equity

High ROE: 241's Return on Equity (-0.2%) is considered low.


Next Steps

Financial Health

How is Alibaba Health Information Technology's financial position?


Financial Position Analysis

Short Term Liabilities: 241's short term assets (CN¥5.2B) exceed its short term liabilities (CN¥3.0B).

Long Term Liabilities: 241's short term assets (CN¥5.2B) exceed its long term liabilities (CN¥65.2M).


Debt to Equity History and Analysis

Debt Level: 241's debt to equity ratio (20.2%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 241's debt to equity ratio has reduced over the past 5 years.


Balance Sheet

Inventory Level: 241 has a low level of unsold assets or inventory.

Debt Coverage by Assets: 241's debt is covered by short term assets (assets are 5.2x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 241 is profitable, therefore cash runway is not a concern.

Forecast Cash Runway: 241 is profitable, therefore cash runway is not a concern.


Next Steps

Dividend

What is Alibaba Health Information Technology's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 241's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 241's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 241's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 241's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 241's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.4yrs

Average board tenure


CEO

Shunyan Zhu (48yo)

0.083

Tenure

Mr. Shunyan Zhu serves as Chairman of the Board and Chief Executive Officer and Executive Director at Alibaba Health Information Technology Limited since March 16, 2020. He is the President of the Innovati ...


Board Members

NamePositionTenureCompensationOwnership
Qiang Wang
CFO & Executive Director1.75yrsCN¥5.01m0.0036% CN¥5.5m
Shunyan Zhu
Chairman of the Board & CEO0.083yrno datano data
Yongming Wu
Non-Executive Director5yrsno data0.010% CN¥16.4m
Chang Meng
Director of Alibaba Health Technology(Beijing) Company Limitedno datano datano data
Tong Luo
Independent Non-Executive Director5.92yrsCN¥293.00kno data
King On Wong
Independent Non-Executive Director5.92yrsCN¥542.00kno data
Lei Wang
Non-Executive Director5yrsCN¥8.27m0.10% CN¥160.8m
Li Ma
Director of Alibaba Health Technology(Beijing) Company Limitedno datano datano data
Hong Xu
Non-Executive Director0.83yrno datano data
Yi Huang
Independent Non-Executive Director0.83yrno datano data

3.4yrs

Average Tenure

45.5yo

Average Age

Experienced Board: 241's board of directors are considered experienced (3.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: 241 insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.5%.


Top Shareholders

Company Information

Alibaba Health Information Technology Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Alibaba Health Information Technology Limited
  • Ticker: 241
  • Exchange: SEHK
  • Founded:
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: HK$156.330b
  • Shares outstanding: 12.06b
  • Website: https://www.alihealth.cn

Number of Employees


Location

  • Alibaba Health Information Technology Limited
  • Tower One
  • 26th Floor
  • Causeway Bay
  • Hong Kong

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALBH.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDAug 1998
TWYDB (Deutsche Boerse AG)YesOrdinary SharesDEEURAug 1998
241SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDAug 1998
TWYBST (Boerse-Stuttgart)YesOrdinary SharesDEEURAug 1998
241SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect)YesOrdinary SharesHKHKDAug 1998
241SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect)YesOrdinary SharesHKHKDAug 1998
ALBB.YOTCPK (Pink Sheets LLC)UNSPONSORD ADRUSUSDJul 2017

Biography

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People’s Republic of China. It engages in business-to-customer (B2C) retail activities; advertisement business; and business-to-business (B2B) centralized procurement distribution business. The company also provides pharmaceutical and healthcare products through its online stores on Tmall.com and offline pharmacy outlets to B2C and B2B customers; marketing services; health consultation services; outsourced and value-added services to the Tmall entities; and telemedicine services. In addition, it trades in pharmaceutical products; and offers network hospital services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. The company is based in Causeway Bay, Hong Kong. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/01 12:58
End of Day Share Price2020/04/01 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.